Lurasidone for the treatment of schizophrenia in adult and paediatric populations

Lurasidone for the treatment of schizophrenia in adult and paediatric populations

Schizophrenia is a common debilitating disorder characterized by significant impairments in how reality is perceived, combined with behavioural changes. In this review, we describe the lurasidone development programme for adult and paediatric patients. Both the pharmacokinetic and pharmacodynamic ch...

Full description

Bibliographic Details
Main Authors: Teresa Guilera, Juan Pablo Chart Pascual, Maria del Carmen Blasco, Pilar Calvo Estopiñán, Rubén Asensio Piernas González, Isabel Ramírez Martínez, Cristóbal Rodríguez Moyano, Rita Prieto Pérez, Irene Gabarda-Inat, Juan L Prados-Ojeda, Marina Diaz-Marsà, Manuel Martín-Carrasco
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2023-02-01
Series:Drugs in Context
Subjects:
case studies
clinical trials
lurasidone
realworld data
schizophrenia
Online Access:https://www.drugsincontext.com/lurasidone-for-the-treatment-of-schizophrenia-in-adult-and-paediatric-populations/

Internet

https://www.drugsincontext.com/lurasidone-for-the-treatment-of-schizophrenia-in-adult-and-paediatric-populations/

Similar Items